Xtant Medical Holdings Inc. (XTNT) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

Per the Roarable RQD rating, XTNT scores 65 out of 100, a letter grade of C, labeled "Roarable Hold — Fair / Balanced Risk-Reward." The five pillars are:

• Fundamental Cash Engine (12/20): Per the Roarable RQD rating, this pillar reflects ROIC of 12.8% and an FCF yield of 24.95%. The FCF yield is high relative to the $0.29 price and $40.7M market cap, which can indicate that cash generation is strong relative to valuation, though the source does not explain the drivers behind it.
• Whale 13F Flow (12/20): Per the Roarable RQD rating, this pillar captures institutional accumulation and options positioning. The moderate score suggests institutional signals are present but not decisive.
• Insider Conviction (16/20): Per the Roarable RQD rating, this is the highest-scoring pillar, based on SEC Form 4 and Congressional PTR cluster flow.
• Macro Regime Fit (13/20): Per the Roarable RQD rating, beta is 1.0 and the score reflects sector sensitivity. A beta of 1.0 implies market-matching volatility, not elevated or dampened exposure.
• Forensic Balance Sheet (12/20): Per the Roarable RQD rating, this pillar cites an Altman Z-Score of 0.2, a Piotroski F-Score of 9/9, and Debt/Equity of 0.22. The Piotroski score is at its maximum, indicating strong fundamental-quality signals, while the Altman Z-Score of 0.2 is a distress-range reading that offsets much of that strength.

For a prospective investor, the rating signals a mixed picture: cash-flow metrics and insider signals support the stock, while the distress-range Altman score and the sub-dollar price warrant caution. Upside drivers would be sustained FCF generation and continued insider conviction; the main valuation tradeoff is that a low absolute price and small market cap coexist with weak bankruptcy-prediction metrics. The rating is analytical, not a recommendation.